CAPTEM (capecitabine and temozolomide) provided a high rate of disease control in patients with typical and atypical lung ...

Results of CheckMate 67T, a phase 3 noninferiority study comparing subcutaneous and intravenous nivolumab formulations in RCC, were presented at JADPRO 2025.

Real-world study confirmed that longer platinum-free interval was associated with better survival and prolonged 2L treatment duration in pts with endometrial cancer.

New research suggests that, among patients with neuroendocrine tumors, primary tumor sites differ by race, and overall survival outcomes differ by tumor site and gender.

From 2003 to 2017, cancer incidence rates increased for several cancer types, with increases in younger and older adults for many cancers, according to a study.

For patients with early-stage cervical cancer, sentinel lymph node biopsy alone is noninferior to lymphadenectomy with respect to disease-free survival.

PRRT retreatment may be well tolerated and confer a survival benefit in patients with well-differentiated, metastatic neuroendocrine tumors, a study suggests.

More than 3,000 people in Britain have sued Johnson & Johnson, claiming its baby powder caused cancer, according to court filings.

For patients with mCSPC with homologous recombination repair gene alterations, the addition of niraparib to abiraterone acetate and prednisone is beneficial.

(HealthDay News) — The U.S. Food and Drug Administration (FDA) announced that it will fast-track review of nine experimental drugs. The move is part of a Trump administration program aimed at ...

We recommend that CTC should be routinely assessed and measured at diagnosis as part of risk evaluation,” study researchers wrote.

Our prediction model provides a useful framework for conveying tailored risk information simply and identifying women who may receive enhanced benefit from specific intervention strategies because ...